MDPROMISE Department, University of Palermo, Palermo, ItalyPalermo, Sicilia, Italy
OC 26.2 - Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: update of an Italian multicenter study
Sunday, June 23, 202415:00 – 15:15 ICT
PB0490 - Real-world outcomes of prophylaxis with extended half-life factor IX products for hemophilia B: a pooled analysis of medical chart data from Germany and Italy
Monday, June 24, 202413:45 – 14:45 ICT
